Destiny Pharma Revenue and Competitors
Estimated Revenue & Valuation
- Destiny Pharma's estimated annual revenue is currently $6.4M per year.
- Destiny Pharma's estimated revenue per employee is $155,000
Employee Data
- Destiny Pharma has 41 Employees.
- Destiny Pharma grew their employee count by 0% last year.
Destiny Pharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CSO | Reveal Email/Phone |
2 | VP, Preclinical Development | Reveal Email/Phone |
Destiny Pharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Destiny Pharma?
Destiny Pharma plc is an established, clinical stage, innovative biotechnology company focused on the development of nobel medicines that represent a new approach to the treatment of infectious disease. These potential new medicines are being developed to address the need for new drugs for the prevention and treatment of life-threatening infections caused by antibiotic resistant bacteria, often referred to as "superbugs". Our proprietary XF-series of compounds have a mechanism of action that is fundamentally different from all existing antibiotics. As the likelihood of resistance developing is very remote, they offer potential advantages in controlling the drug-resistant bacteria that are at the centre of a global healthcare crisis.
keywords:N/A
N/A
Total Funding
41
Number of Employees
$6.4M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Destiny Pharma News
Destiny Pharma PLC (AIM:DEST) said its strengthened balance sheet provides it with the opportunity to take its two late-stage assets to value...
Destiny Pharma is a clinical stage, innovative biotechnology company focused on the development of novel medicines that can prevent life-...
Destiny Pharma's 29021 year-end cash of £4.65mln together with a £6.5mln fundraise in March 2022 provides a funding runway into mid-2023,...
Other Companies in Brighton
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5M | 42 | 20% | N/A |
#2 | $8.4M | 42 | 45% | N/A |
#3 | $6.9M | 42 | -18% | N/A |
#4 | $11.1M | 42 | -9% | N/A |
#5 | $12.1M | 43 | -10% | N/A |